Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study

1. Pedrol, E.
2. Caro-Murillo, A.M.
3. Castaño, M.A.
4. Riera, M.
5. Olalla, J.
6. Domingo, P.
7. Arazo, P.
8. Gómez-Sirvent, J.L.
9. Pulido, F.
10. Romero-Palacios, A.
11. Aguirrebengoa, K.
12. Vera, F.
13. Ferrer, P.
14. Blanco Ramos, J.R.